Cargando…
Proteomic Alteration in the Progression of Multiple Myeloma: A Comprehensive Review
Multiple myeloma (MM) is an incurable hematologic malignancy. Most MM patients are diagnosed at a late stage because the early symptoms of the disease can be uncertain and nonspecific, often resembling other, more common conditions. Additionally, MM patients are commonly associated with rapid relaps...
Autores principales: | Ismail, Nor Hayati, Mussa, Ali, Al-Khreisat, Mutaz Jamal, Mohamed Yusoff, Shafini, Husin, Azlan, Johan, Muhammad Farid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10378430/ https://www.ncbi.nlm.nih.gov/pubmed/37510072 http://dx.doi.org/10.3390/diagnostics13142328 |
Ejemplares similares
-
The Global Prevalence of Vitamin D Deficiency and Insufficiency in Patients with Multiple Myeloma: A Systematic Review and Meta-Analysis
por: Ismail, Nor Hayati, et al.
Publicado: (2023) -
Dysregulation of Non-Coding RNAs: Roles of miRNAs and lncRNAs in the Pathogenesis of Multiple Myeloma
por: Ismail, Nor Hayati, et al.
Publicado: (2023) -
The Role of Epigenetics in the Development and Progression of Multiple Myeloma
por: Ismail, Nor Hayati, et al.
Publicado: (2022) -
Worldwide Prevalence of Epstein–Barr Virus in Patients with Burkitt Lymphoma: A Systematic Review and Meta-Analysis
por: Al-Khreisat, Mutaz Jamal, et al.
Publicado: (2023) -
Clinical and Laboratory Features of JAK2 V617F, CALR, and MPL Mutations in Malaysian Patients with Classical Myeloproliferative Neoplasm (MPN)
por: Zulkeflee, Razan Hayati, et al.
Publicado: (2021)